人工心臓弁(生体弁)の世界市場2016-2020

◆英語タイトル:Global Tissue Heart Valves Market 2016-2020
◆商品コード:IRTNTR8800
◆発行会社(リサーチ会社):Technavio
◆発行日:2016年2月24日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,000 ⇒換算¥226,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、人工心臓弁(生体弁)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、人工心臓弁(生体弁)の世界市場規模及び予測、製品別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、コスト分析、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About Tissue Heart Valves

Heart valves are prosthetic cardiovascular medical devices that are used to replace a defective heart valve. These valves can be biological (tissue) or mechanical. Manufacturers develop tissue heart valves from various sources such as bovine, porcine, and human tissues. Devices developed using human tissues are known as allografts or homografts. The implantation of these devices does not require the lifelong use of blood-thinner medications compared to mechanical tissue heart valves. They also ensure unidirectional flow of the blood across heart chambers. The medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.

Technavio’s analysts forecast the global tissue heart valves market to grow at a CAGR of 3.81% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global tissue heart valves market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of tissue heart valve implants.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Tissue Heart Valves Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Edwards Lifesciences
• LivaNova
• Medtronic
• St. Jude Medical

[Other prominent vendors]
• Braile Biomédica
• CryoLife
• Labcor Laboratórios

[Market driver]
• Demand for stentless tissue valves
• For a full, detailed list, view our report

[Market challenge]
• Lack of skilled personnel
• For a full, detailed list, view our report

[Market trend]
• Increase in M&A
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Cost analysis
• Cost analysis of valve replacement procedures

PART 07: Market segmentation by product

PART 08: Geographical segmentation
• Tissue heart valves market in Americas
• Tissue heart valves market in EMEA
• Tissue heart valves market in APAC

PART 09: Market drivers
• Prevalence of heart valve diseases
• Demand for stentless tissue valves
• Implementation of MI procedures
• Rise in geriatric population

PART 10: Impact of drivers

PART 11: Market challenges
• Use of alternative products
• Risk of potential complications
• Lack of skilled personnel
• Stringent regulatory framework

PART 12: Impact of drivers and challenges

PART 13: Market trends
• Demand for tissue heart valves in APAC
• Preference among geriatric population
• Increase in M&A

PART 14: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Edwards Lifesciences
• LivaNova
• Medtronic
• St. Jude Medical
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

PART 16: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global tissue heart valves market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Cost comparison of heart valve replacement procedures (high-risk group)
Exhibit 05: Global tissue heart valves market segmentation by product
Exhibit 06: Global tissue heart valves market segmentation by product 2015
Exhibit 07: Global tissue heart valves market segmentation by geography 2015
Exhibit 08: Global tissue heart valves market segmentation by geography 2020
Exhibit 09: Global tissue heart valves market segmentation by geography 2015-2020
Exhibit 10: Tissue heart valves market in Americas 2015-2020 ($ millions)
Exhibit 11: Tissue heart valves market in US 2015-2020 ($ millions)
Exhibit 12: Tissue heart valves market in EMEA 2015-2020 ($ millions)
Exhibit 13: Tissue heart valves market in APAC 2015-2020 ($ millions)
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Cost comparison of heart valve replacement procedures
Exhibit 17: Ranking of top vendors 2015
Exhibit 18: Edwards Lifesciences: Key takeaways
Exhibit 19: LivaNova: Key takeaways
Exhibit 20: Medtronic: Key product offerings
Exhibit 21: Medtronic: Key takeaways
Exhibit 22: St. Jude Medical: Key takeaways



【掲載企業】

Edwards Lifesciences, LivaNova, Medtronic, St. Jude Medical, Braile Biomédica, CryoLife, Labcor Laboratórios

【レポートのキーワード】

人工心臓弁、生体弁、インプラント、医療機器

【リサーチ方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[人工心臓弁(生体弁)の世界市場2016-2020]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆